Pediatrik Nöroloji Hastalarında Salya Yönetimi
Özet
Siyalore, 3-4 yaşından büyük çocuklarda nörolojik nedenlere bağlı olarak görülen istemsiz tükürük kaybıdır ve sosyal, ciltsel veya solunumla ilgili ciddi komplikasyonlara yol açabilir. Bu durumun yönetiminde temel olarak davranış terapisi, antikolinerjik ajanlar içeren farmakolojik tedaviler, botulinum toksin enjeksiyonları ve cerrahi müdahaleler gibi farklı yaklaşımlar kullanılmaktadır. Uygulanan tedavilerin başarısı hastadan hastaya değişmekle birlikte, tek bir kesin çözüm yöntemi bulunmamaktadır. Tedavi seçimi, çocuğun nörolojik durumuna ve salya akmasının şiddetine göre planlanmalıdır.
Sialorrhea is the involuntary loss of saliva in children older than 3-4 years, often stemming from neurological disorders, which can lead to significant social, dermatological, and respiratory complications. Management strategies include behavioral therapy, pharmacological interventions with anticholinergic agents, botulinum toxin injections, and surgical procedures. While these treatments are widely used, their success varies significantly from patient to patient, and no universal definitive cure currently exists. Treatment plans must be tailored based on the child's specific neurological condition and the severity of the drooling.
Referanslar
Reddihough D, Erasmus CE, Johnson H, McKellar GM, Jongerius PH. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. European journal of neurology. Aug 2010;17 Suppl 2:109-121.
Dias BL, Fernandes AR, Maia Filho HS. Sialorrhea in children with cerebral palsy. Jornal de pediatria. Nov - Dec 2016;92(6):549-558.
Erasmus CE, Van Hulst K, Rotteveel LJ, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Developmental medicine and child neurology. Jun 2009;51(6):454-459.
Senner JE, Logemann J, Zecker S, Gaebler-Spira D. Drooling, saliva production, and swallowing in cerebral palsy. Developmental medicine and child neurology. Dec 2004;46(12):801-806.
Little SA, Kubba H, Hussain SS. An evidence-based approach to the child who drools saliva. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. Jun 2009;34(3):236-239.
McInerney MS, Reddihough DS, Carding PN, Swanton R, Walton CM, Imms C. Behavioural interventions to treat drooling in children with neurodisability: a systematic review. Developmental medicine and child neurology. Jan 2019;61(1):39-48.
Eiland LS. Glycopyrrolate for chronic drooling in children. Clinical therapeutics. Apr 2012;34(4):735-742.
Mato A, Limeres J, Tomas I, et al. Management of drooling in disabled patients with scopolamine patches. British journal of clinical pharmacology. Jun 2010;69(6):684-688.
Reddihough D, Johnson H, Staples M, Hudson I, Exarchos H. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Developmental medicine and child neurology. Nov 1990;32(11):985-989.
Montgomery J, McCusker S, Lang K, et al. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic. International journal of pediatric otorhinolaryngology. Jun 2016;85:33-39.
Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreels FJ, van Hulst K, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. Sep 2004;114(3):620-627.
Greensmith AL, Johnstone BR, Reid SM, Hazard CJ, Johnson HM, Reddihough DS. Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experience. Plastic and reconstructive surgery. Oct 2005;116(5):1233-1242.
